A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P, Ross M, Gilbert C, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin M, Kurtzberg J, Peters WP.
Elkordy M, et al. Among authors: peters wp.
Bone Marrow Transplant. 1997 Feb;19(4):315-22. doi: 10.1038/sj.bmt.1700633.
Bone Marrow Transplant. 1997.
PMID: 9051240
Clinical Trial.